Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Mobile Health for Adherence in Breast Cancer Patients

Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
ECOG-ACRIN Cancer Research Group
Status
Recruiting
NCT ID
NCT06112613
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Intervention
Electronic Health Record Review, Health Promotion and Education, Health Telemonitoring, Interview, Patient Navigation, Survey Administration, Text Message-Based Navigation Intervention
Condition
Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, HER2-Negative Breast Carcinoma, Hormone Receptor-Positive Breast Carcinoma
Investigators
Gelareh Sadigh, John M. Schallenkamp, Maria T. Grosse-Perdekamp, Charissa K. Williams, Deborah W. Wilbur, Jay W. Carlson, Joseph J. Merchant, Site Public Contact, Seema Harichand-Herdt, William J. Irvin, Debra P. Ritzwoller, Brian L. Burnette, Kathleen J. Yost, Asheesh Shipstone, Rose A. Juhasz, William E. Burak, Howard M. Gross, Victor T. Lin, Luis J. Santos Reyes, Gregory A. Masters, Jonathan S. Treisman, Nicholas DiBella, David M. King, Samuel N. Ofori, Anjali V. Desai, Della F. Makower, Adedayo A. Onitilo, Daniel Almquist, Susan Burdette-Radoux, John A. Ellerton, Shahzad Siddique, Bernard Tawfik, Ahmed I. Megahed, Hannah Alley, Elizabeth D. Barrows, Sharad A. Ghamande, Jennifer R. Collins, Erica Doubleday, Michelle M. Loch
CT Research Area
Symptom Science

See list of participating sites